Short answer
PULSE BIOSCIENCES, INC. (PLSE) filed an 8-K current report with the SEC on May 6, 2026 reporting Item 8.01 (Other Events). ATM equity program permits sales up to $59,976,196, creating potential dilution for existing shareholders.
PULSE BIOSCIENCES, INC. 8-K event analysis
AI summary of each reported item and its exhibits
Item 8.01 · Other Events
- ATM equity program permits sales up to $59,976,196, creating potential dilution for existing shareholders
- Company affiliates may purchase shares through TD Cowen at prevailing market prices without discounts
- Robert Duggan, controlling shareholder with approximately 72% ownership, likely near-term buyer
- CEO and Co-Chairman Paul LaViolette also indicated likely purchases, but neither individual made a binding commitment
- Insider participation could provide financing support while preserving control concentration; actual purchases remain uncertain
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other PULSE BIOSCIENCES, INC. 8-K filings
Get the next PLSE 8-K as it lands
Follow PLSE for push alerts, or ask the research agent what this filing means.